[1] |
CATTERALL WA.Sodium channels, inherited epilepsy, and antiepileptic drugs[J].Annu Rev Pharmacol Toxicol, 2014, 54:317. |
[2] |
YU FH, MANTEGAZZA M, WESTENBROEK RE, et al.Reduced sodium current in GABAergic interneurons in a mouse model of severe myoclonic epilepsy in infancy[J].Nat Neurosci, 2006, 9(9):1142. |
[3] |
KALUME F, YU FH, WESTENBROEK RE, et al.Reduced sodium current in Purkinje neurons from Nav1.1 mutant mice:implications for ataxia in severe myoclonic epilepsy in infancy[J].J Neurosci, 2007, 27(41):11065. |
[4] |
HAN S, TAI C, WESTENBROEK RE, et al.Autistic-like behaviour in SCN1A+/-mice and rescue by enhanced GABA-mediated neurotransmission[J].Nature, 2012, 489(7416):385. |
[5] |
FANG ZX, HONG SQ, LI TS, et al.Genetic and phenotypic characteristics of SCN1A-related epilepsy in Chinese children[J].Neuroreport, 2019, 30(9):671. |
[6] |
MENG H, XU HQ, YU L, et al.The SCN1A mutation database:updating information and analysis of the relationships among genotype, functional alteration, and phenotype[J].Hum Mutat, 2015, 36(6):573. |
[7] |
CLAES L, CEULEMANS B, AUDENAERT D, et al.De novo SCN1A mutations are a major cause of severe myoclonic epilepsy of infancy[J].Hum Mutat, 2003, 21(6):615. |
[8] |
MULLEY JC, SCHEFFER IE, PETROU S, et al.SCN1A mutations and epilepsy[J].Hum Mutat, 2005, 25(6):535. |
[9] |
DEPIENNE C, TROUILLARD O, SAINT-MARTIN C, et al.Spectrum of SCN1A gene mutations associated with Dravet syndrome:analysis of 333 patients[J].J Med Genet, 2009, 46(3):183. |
[10] |
ESCAYG A, MACDONALD BT, MEISLER MH, et al.Mutations of SCN1A, encoding a neuronal sodium channel, in two families with GEFS+2[J].Nat Genet, 2000, 24(4):343. |
[11] |
SADLEIR LG, MOUNTIER EI, GILL D, et al.Not all SCN1A epileptic encephalopathies are Dravet syndrome:Early profound Thr226Met phenotype[J].Neurology, 2017, 89(10):1035. |
[12] |
田小娟, 张月华, 杨小玲, 等.547例Dravet综合征患儿SCN1A基因突变与遗传特点研究[J].癫痫杂志, 2016, 2(1):3. |
[13] |
DE LANGE IM, GUNNING B, SONSMA A, et al.Influence of contraindicated medication use on cognitive outcome in Dravet syndrome and age at first afebrile seizure as a clinical predictor in SCN1A-related seizure phenotypes[J].Epilepsia, 2018, 59(6):1154. |
[14] |
CETICA V, CHIARI S, MEI D, et al.Clinical and genetic factors predicting Dravet syndrome in infants with SCN1A mutations[J].Neurology, 2017, 88(11):1037. |
[15] |
SEINFELD S, GOODKIN HP, SHINNAR S.Status Epilepticus[J].Cold Spring Harb Perspect Med, 2016, 6(3):a022830. |
[16] |
BRUNKLAUS A, ZUBERI SM.Dravet syndrome——from epileptic encephalopathy to channelopathy[J].Epilepsia, 2014, 55(7):979. |
[17] |
LEE YJ, YUM MS, KIM MJ, et al.Large-scale structural alteration of brain in epileptic children with SCN1A mutation[J].Neuroimage Clin, 2017, 15:594. |
[18] |
KONG Y, YAN K, HU L, et al.Association between SCN1A and SCN2A mutations and clinical/EEG features in Chinese patients from epilepsy or severe seizures[J].Clin Chim Acta, 2018, 483:14. |
[19] |
KWAN P, BRODIE MJ.Early identification of refractory epilepsy[J].N Engl J Med, 2000, 342(5):314. |
[20] |
BRUNKLAUS A, ELLIS R, REAVEY E, et al.Prognostic, clinical and demographic features in SCN1A mutation-positive Dravet syndrome[J].Brain, 2012, 135(Pt 8):2329. |
[21] |
STRIANO P, COPPOLA A, PEZZELLA M, et al.An open-label trial of levetiracetam in severe myoclonic epilepsy of infancy[J].Neurology, 2007, 69(3):250. |
[22] |
ZHANG Y, XU J, ZHANG K, et al.The anticonvulsant effects of ketogenic diet on epileptic seizures and potential mechanisms[J].Curr Neuropharmacol, 2018, 16(1):66. |
[23] |
TIAN X, CHEN J, ZHANG J, et al.The efficacy of ketogenic diet in 60 chinese patients with dravet syndrome[J].Front Neurol, 2019, 10:625. |
[24] |
KO A, JUNG DE, KIM SH, et al.The efficacy of ketogenic diet for specific genetic mutation in developmental and epileptic encephalopathy[J].Front Neurol, 2018, 9:530. |
[25] |
YAN N, XIN-HUA W, LIN-MEI Z, et al.Prospective study of the efficacy of a ketogenic diet in 20 patients with Dravet syndrome[J].Seizure, 2018, 60:144. |
[26] |
KOSSOFF EH, ZUPEC-KANIA BA, AUVIN S, et al.Optimal clinical management of children receiving dietary therapies for epilepsy:updated recommendations of the International Ketogenic Diet Study Group[J].Epilepsia Open, 2018, 3(2):175. |
[27] |
ISMAYILOVA N, LEUNG MA, KUMAR R, et al.Ketogenic diet therapy in infants less than two years of age for medically refractory epilepsy[J].Seizure, 2018, 57:5. |